Literature DB >> 28550588

Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.

Matthias Eberhard1,2, Monika Mastalerz3, Jovana Pavicevic4, Thomas Frauenfelder3, Fabian Nietlispach4, Francesco Maisano4, Felix C Tanner4, Thi Dan Linh Nguyen-Kim3.   

Abstract

To assess the value of computed tomography (CT) for non-invasive detection of pulmonary hypertension (PH) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and to correlate CT measurements and signs with mortality after TAVI. 257 TAVI patients (median 84 years; 134 females) with both right heart catheterisation (RHC) and CT within 3 days were retrospectively analyzed. According to guidelines PH was defined as mean pulmonary artery pressure ≥25 mmHg in RHC. CT-signs for PH assessment were evaluated. Clinical data was recorded before and at 30 days, 1 year and 2 years after TAVI. 161 patients exhibited PH (median 83 years; 90 females). In patients with PH, main pulmonary artery diameter (MPA; p < 0.001) and anterior pericardial recess (PR; p = 0.003) were significantly larger. Furthermore, pleural effusion (p < 0.001) was significantly more common. Sensitivity and specificity for predicting PH were calculated for MPA diameter ≥29 mm (56 and 61%), PR diameter ≥10 mm (37 and 82%), and presence of pleural effusion (42 and 91%). Patients with PH showed significantly higher 2 years mortality after TAVI (30 vs. 17%; p = 0.01) with a Hazard ratio (HR) of 2.5 (95% CI 1.1-5.8; p = 0.027). Pleural effusion was a predictor of higher 2-year-all-cause mortality after TAVI (42 vs. 20%; p = 0.022) with a HR of 2.0 (95% CI 1.0-3.8; p = 0.042). Patients with symptomatic AS and PH at baseline display higher 2 year-all-cause mortality after TAVI. Several CT-signs suggest the presence of PH in TAVI patients with moderate to high specificity, but low sensitivity. Pleural effusion in CT is a predictor of higher 2 year-all-cause mortality.

Entities:  

Keywords:  Aortic stenosis; Multislice computed tomography; Pleural effusion; Pulmonary artery diameter; Pulmonary hypertension; Transcatheter aortic valve implantation

Mesh:

Year:  2017        PMID: 28550588     DOI: 10.1007/s10554-017-1180-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  39 in total

1.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

2.  Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.

Authors:  Corrado Tamburino; Davide Capodanno; Angelo Ramondo; Anna Sonia Petronio; Federica Ettori; Gennaro Santoro; Silvio Klugmann; Francesco Bedogni; Francesco Maisano; Antonio Marzocchi; Arnaldo Poli; David Antoniucci; Massimo Napodano; Marco De Carlo; Claudia Fiorina; Gian Paolo Ussia
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

3.  Prognostic value of aortic regurgitation after TAVI in patients with chronic kidney disease.

Authors:  Mathias Possner; Jan Vontobel; Thi Dan Linh Nguyen-Kim; Christoph Zindel; Erik W Holy; Simon F Stämpfli; Michel Zuber; Philipp A Kaufmann; Fabian Nietlispach; Francesco Maisano; Markus Niemann; Felix C Tanner
Journal:  Int J Cardiol       Date:  2016-06-25       Impact factor: 4.164

4.  Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy.

Authors:  S V Abramson; J F Burke; J J Kelly; J G Kitchen; M J Dougherty; D F Yih; F C McGeehin; J W Shuck; T P Phiambolis
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

5.  CT measurement of main pulmonary artery diameter.

Authors:  P D Edwards; R K Bull; R Coulden
Journal:  Br J Radiol       Date:  1998-10       Impact factor: 3.039

6.  Determinants of pulmonary hypertension development in moderate or severe aortic stenosis.

Authors:  Hyo-Suk Ahn; Sung-A Chang; Hyung-Kwan Kim; Seon Jin Kim; Seung-Pyo Lee; Sung-Ji Park; Yong-Jin Kim; Goo-Yeong Cho; Dae-Won Sohn; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2014-07-22       Impact factor: 2.357

7.  Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure.

Authors:  Bart Boerrigter; Gert-Jan Mauritz; J Tim Marcus; Frank Helderman; Pieter E Postmus; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Chest       Date:  2010-05-21       Impact factor: 9.410

8.  Prevalence of pulmonary hypertension associated with severe acute respiratory distress syndrome: predictive value of computed tomography.

Authors:  Martin Beiderlinden; Hilmar Kuehl; Tanja Boes; Jürgen Peters
Journal:  Intensive Care Med       Date:  2006-04-14       Impact factor: 17.440

9.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

10.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.

Authors:  Josep Rodés-Cabau; John G Webb; Anson Cheung; Jian Ye; Eric Dumont; Christopher M Feindel; Mark Osten; Madhu K Natarajan; James L Velianou; Giuseppe Martucci; Benoît DeVarennes; Robert Chisholm; Mark D Peterson; Samuel V Lichtenstein; Fabian Nietlispach; Daniel Doyle; Robert DeLarochellière; Kevin Teoh; Victor Chu; Adrian Dancea; Kevin Lachapelle; Asim Cheema; David Latter; Eric Horlick
Journal:  J Am Coll Cardiol       Date:  2010-01-22       Impact factor: 24.094

View more
  5 in total

Review 1.  Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Elke Boxhammer; Alexander E Berezin; Vera Paar; Nina Bacher; Albert Topf; Sergii Pavlov; Uta C Hoppe; Michael Lichtenauer
Journal:  J Pers Med       Date:  2022-04-08

2.  Pre-procedural CT angiography inferior vena cava measurements: a predictor of mortality in patients undergoing transcatheter aortic valve implantation.

Authors:  Matthias Eberhard; Gianluca Milanese; Michael Ho; Stefan Zimmermann; Thomas Frauenfelder; Fabian Nietlispach; Francesco Maisano; Felix C Tanner; Thi Dan Linh Nguyen-Kim
Journal:  Eur Radiol       Date:  2018-07-17       Impact factor: 5.315

3.  Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Crochan J O'Sullivan; Matteo Montalbetti; Rainer Zbinden; David J Kurz; Alain M Bernheim; Aaron Liew; Matthias R Meyer; David Tüller; Franz R Eberli
Journal:  Front Cardiovasc Med       Date:  2018-06-05

4.  Dual-Energy CT Pulmonary Angiography for the Assessment of Surgical Accessibility in Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Matthias Eberhard; Micheal McInnis; Marc de Perrot; Mona Lichtblau; Silvia Ulrich; Ilhan Inci; Isabelle Opitz; Thomas Frauenfelder
Journal:  Diagnostics (Basel)       Date:  2022-01-18

5.  Larger pulmonary artery to ascending aorta ratios are associated with decreased survival of patients undergoing pulmonary endarterectomy.

Authors:  Panja M Boehm; Stefan Schwarz; Jürgen Thanner; Cecilia Veraar; Mario Gerges; Christian Gerges; Irene Lang; Paul Apfaltrer; Helmut Prosch; Shahrokh Taghavi; Walter Klepetko; Hendrik Jan Ankersmit; Bernhard Moser
Journal:  JTCVS Open       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.